Stimulated apoptosis as an anti-neoplastic strategy

Surgery

Volumn 127, Issue 4, 2000, Pages 366-369

  Arya, Jyoti ^a,b   Finlayson, Christina A ^a,b   Shames, Brian D ^a,b   Harken, Alden H ^a,b   Anderson, Ben O ^a,b  

^a University of Washington ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CHINESE DRUG; DOXORUBICIN; FLUOROURACIL; HEAT SHOCK PROTEIN; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAPACHONE; MITOCHONDRIAL ENZYME; ONCOPROTEIN; PLANT EXTRACT; PROTEIN BCL 2; PROTEIN P53; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

APOPTOSIS; CELL DEATH; CHINESE MEDICINE; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HERBAL MEDICINE; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

EID: 0034000780     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.103163     Document Type: Article

References (39)

1. 1. Cai Z, Korner M, Tarantino N, Chouaib S. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κK B activation but not tumor necrosis factor-α - induced apoptosis. J Biol Chem 1997;272:96-101.
2. 2. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson F.P, Casciola-Rosen LA, et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 1998;140:1485-95.
3. 3. Volm M, Koomagi R. The implications of proliferation and apoptosis for lung cancer metastasis. Oncol Rep 1999;6:373-6.
4. 4. Meldrum D, Dinarello CA, Shames BD, Cleveland JC Jr, Cain BS, Banerjee A, et al. Ischemic preconditioning decreases post-ischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation 1998;98:11214-8.
5. 5. Klein P, Muggia FM. Cytoprotection: shelter from the storm. Oncologist 1999;4:112-21.
6. 6. Mancini M, Anderson BO, Caldewell E, Sedghinasab M, Paty PB, Hockenbery DM. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in human colon carcinoma cell line. J Cell Biol 1997;138:449-69.
7. 7. Chan PK, Chan FY. A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin. Biochem Pharmacol 1999;57:1265-73.
8. 8. Wang CY, Mayo MW, Baldwin AS Jr. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NFκB. Science 1996;274:784-7.
9. 9. vanAntwerp DJ, Martin SJ, Kafri T, Green D, Verma IM. Suppression of TNF-α induced apoptosis by NFκB. Science 1996;274:787-9.
10. 10. Liu Z-G, Hsu H, Goeddel D, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NFκB activation prevents cell death. Cell 1996;87:565-76.
11. 11. Green D. Apoptotic pathways: the roads to ruin. Cell 1998;94:695-8.
12. 12. Hebert MJ, Gullans SR, Mackenzie HS, Brady HR. Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1 beta-dependent paracrine loop. Am J Pathol 1998;152:523-32.
13. 13. Behrns KE, Schrum LW, Que FG. Apoptosis: cell death by proteolytic scalpel. Surgery 1999;126:463-8.
14. 14. Rokhlin OW, Hostager BS, Bishop GA, Sidorenk SP, Glover RA, Gudkow AV, et al. Dominant nature of the resistance to Fas-and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997;57:3941-3.
15. 15. Meng X, Brown JM, Ao L, Nordeen SK, Franklin W, Harken AH, et al. Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats. Am J Physiol 1996;271:C1316-24.
16. 16. Bounias M, Kladny J, Kruk I, Michalska T, Lichszteld K. Effects of catechols on free radical formation by chemotherapeutic agents (Adriamycin, Pharmorubicin, and mitomycin). Cancer Detect Prev 1997;21:553-62.
17. 17. Jacob AK, Hotchkiss RS, DeMeester SL, Hiramatsu M, Karl IE, Swanson PI, et al. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery 1997;122:246-53.
18. 18. Baichwal VR, Baeuerle PA: Apoptosis. Activate NFκB or die? Curr Biol 1997;7:R94-R96.
19. 19. Beg AA, Baltimore D. An essential role for NF kappa B in preventing TNF-alpha-induced cell death. Science 1996;274:782-4.
20. 20. DeMeester SL, Buchman TG, Qiu Y, Jacob AK, Dunnigan K, Hotchkiss RS, et al. Heat shock induces IκB-α and prevents stress-induced endothelial cell apoptosis. Arch Surg 1997;132:1283-8.
21. 21. Hu X, Yee E, Harlan JM, Wong F, Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 1998;92:2759-65.
22. 22. Inada T, Kikuyama S, Ichikawa A, Igarashi S, Ogata Y. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma. Anticancer Res 1998;18:2003-10.
23. 23. Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308.
24. 24. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci U S A 1996;93:14486-91.
25. 25. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996;85:803-15.
26. 26. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, et al. Two CD95 (Apo-1/Fas) signaling pathways. EMBO J 1998;17:1675-87.
27. 27. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, et al. Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. Am J Physiol 1998;275:H1084-91.
28. 28. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 1990;171:35-47.
29. 29. Yao J, Mackman N, Edgington TS, Fan ST. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem 1997;272:17795-801.
30. 30. Wadgaonkar R, Phelps KM, Haque Z, Williams AJ, Silverman ES, Collins T. CREB-binding protein is a nuclear integrator of nuclear factor-κB and p53 signaling. J Biol Chem 1999;274:1879-82.
31. 31. Webster GA, Perkins ND. Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 1999;19:3485-95.
32. 32. Opipari AW Jr, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 1990;265:14705-8.
33. 33. Lee KY, Chang W-T, Qui D, Kao PN, Rosen GD. PG490 (triptolide) cooperates with tumor necrosis factor-α to induce apoptosis in tumor cells. J Biol Chem 1999;274:13451-5.
34. 34. Manna SK, Gad YP, Mukhopadhysy A, Aggarwal BB. Suppression of tumor necrosis factor-activated nuclear transcription factor-κB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by β-lapachone. Biochem Pharmacol 1999;57:763-74.
35. 35. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155-62.
36. 36. Kinloch RA, Treherne JM, Furness LM, Hajimohamadreza I. The pharmacology of apoptosis. Trends Pharmacol Sci 1999;20:35-42.
37. 37. Fisher TC, Millner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 1993;53:3321-6.
38. 38. Volm M, Koomagi R. The implications of proliferation and apoptosis for lung cancer metastases. Oncol Rep 1999;6:373-6.
39. 39. Berchem GJ, Bosseler M, Mine N, Avalosse B. Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2. Anticancer Res 1999;19:535-40.